Publications

Day C.J, Favuzza P, Bielfeld S, Haselhorst T, Seefeldt L, Hauser J, Shewell L.K, Flück C, Poole J, Jen F.E.-C, Schäfer A, Dangy J.-P, Gilberger T.-W, França C.T, Duraisingh M.T, Tamborrini M, Brancucci N.M.B, Grüring C, Filarsky M, Jennings M.P, Pluschke G. The essential malaria protein PfCyRPA targets glycans to invade erythrocytes. Cell Rep. 2024;43(4):114012. DOI: 10.1016/j.celrep.2024.114012

Tamborrini M, Schäfer A, Hauser J, Zou L, Paris D.H, Pluschke G. The malaria blood stage antigen PfCyRPA formulated with the TLR-4 agonist adjuvant GLA-SE elicits parasite growth inhibitory antibodies in experimental animals. Malar J. 2023;22:210. DOI: 10.1186/s12936-023-04638-8

Fernandes B, Sousa M, Castro R, Schäfer A, Hauser J, Schulze K, Amacker M, Tamborrini M, Pluschke G, Alves P.M, Fleury S, Roldão A. Scalable process for high-yield production of PfCyRPA using insect cells for inclusion in a malaria virosome-based vaccine candidate. Front Bioeng Biotechnol. 2022;10:879078. DOI: 10.3389/fbioe.2022.87907

Tamborrini M, Hauser J, Schäfer A, Amacker M, Favuzza P, Kyungtak K, Fleury S, Pluschke G. Vaccination with virosomally formulated recombinant CyRPA elicits protective antibodies against Plasmodium falciparum parasites in preclinical in vitro and in vivo models. Vaccines. 2020;5:9. DOI: 10.1038/s41541-020-0158-9

Röltgen K, Rose N, Ruggieri A, Warryn L, Scherr N, Pinho-Nascimento C.A, Tamborrini M, Jaenisch T, Pluschke G. Development of dengue virus serotype-specific NS1 capture assays for the rapid and highly sensitive identification of the infecting serotype in human sera. J Immunol. 2018;200(200):3857-3866. DOI: 10.4049/jimmunol.1701790

Bertolotti A, Haas P, Haueter I, Käser M, Kronig M, Mörgeli S, Schwarz S, Tamborrini M, Waser M. Umfrage zur Kundenzufriedenheit und zum Verbesserungs-Potential der Administration – Schlussbericht. Basel: Swiss Tropical and Public Health Institute, 2017

Favuzza P, Guffart E, Tamborrini M, Scherer B, Dreyer A.M, Rufer A.C, Erny J, Hoernschemeyer J, Thoma R, Schmid G, Gsell B, Lamelas A, Benz J, Joseph C, Matile H, Pluschke G, Rudolph M.G. Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibody. eLife. 2017;6:e20383. DOI: 10.7554/eLife.20383

Favuzza P, Blaser S, Dreyer A.M, Riccio G, Tamborrini M, Thoma R, Matile H, Pluschke G. Generation of Plasmodium falciparum parasite-inhibitory antibodies by immunization with recombinantly-expressed CyRPA. Malar J. 2016;15:161. DOI: 101.1186/s12936-016-1213-x

Rose N, Pinho-Nascimento C.A, Ruggieri A, Favuzza P, Tamborrini M, Roth H, Baroni de Moraes M.T, Matile H, Janisch T, Pluschke G, Roltgen K. Generation of monoclonal antibodies against native viral proteins using antigen-expressing mammalian cells for mouse immunization. BMC Biotechnol. 2016;16:83. DOI: 10.1186/s12896-016-0314-5

Favuzza P, Blaser S, Dreyer A, Tamborrini M, Matile H, Pluschke G. Novel approaches for the identification and profiling of new Plasmodium falciparum antigens as promising blood-stage candidates for inclusion in a malaria subunit vaccine. Trop Med Int Health, 2015;20(Suppl. 1):20-21

Silbereisen A, Tamborrini M, Wittwer M, Schürch N, Pluschke G. Development of a bead-based Luminex assay using lipopolysaccharide specific monoclonal antibodies to detect biological threats from Brucella species. BMC Microbiol. 2015;15:198. DOI: 10.1186/s12866-015-0534-1

Silbereisen A, Tamborrini M, Wittwer M, Urch N.S, Pluschke G. Development of a bead-based Luminex assay using lipopolysacharide specific monoclonal antibodies for the detection of bio threat Brucella species. Trop Med Int Health, 2015;20(Suppl. 1):394

Tamborrini M, Geib N, Marrero-Nodarse A, Jud M, Hauser J, Aho C, Lamelas A, Zuniga A, Pluschke G, Ghasparian A, Robinson J.A. A synthetic virus-like particle streptococcal vaccine candidate using B-cell epitopes from the proline-rich region of pneumococcal surface protein A. Vaccine. 2015;3(4):850-874. DOI: 10.3390/vaccines3040850

Bauer M, Chicca A, Tamborrini M, Eisen D, Lerner R, Lutz B, Poetz O, Pluschke G, Gertsch J. Identification and qualification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors. J Biol Chem. 2012;287(44):36944-36967. DOI: 10.1074/jbc.M112.382481

Pluschke G, Tamborrini M. Development of a virosomal malaria vaccine candidate: from synthetic peptide design to clinical concept validation. Future Virol. 2012;7(8):779-790. DOI: 10.2217/fvl.12.74

Ghasparian A, Riedel T, Koomullil J, Moehle K, Gorba C, Svergun D.I, Perriman A.W, Mann S, Tamborrini M, Pluschke G, Robinson J.A. Engineered synthetic virus-like particles and their use in vaccine delivery. ChemBioChem. 2011;12(1):100-109. DOI: 10.1002/cbic.201000536

Tamborrini M, Bauer M, Bolz M, Maho A, Oberli M.A, Werz D.B, Schelling E, Zinsstag J, Seeberger P.H, Frey J, Pluschke G. Identification of an African Bacillus anthracis lineage that lacks expression of the spore surface associated anthrose containing oligosaccharide. J Bacteriol. 2011;193(14):3506-3511. DOI: 10.1128/JB.00078-11

Tamborrini M, Stoffel S.A, Westerfeld N, Amacker M, Theisen M, Zurbriggen R, Pluschke G. Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations. Malar J. 2011;10:359. DOI: 10.1186/1475-2875-10-359

Oberli M.A, Tamborrini M, Tsai Y.H, Werz D.B, Horlacher T, Adibekian A, Gauss D, Möller H.M, Pluschke G, Seeberger P.H. Molecular analysis of carbohydrate-antibody interactions: case study using a Bacillus anthracis tetrasaccharide. J Am Chem Soc. 2010;132(30):10239-10241. DOI: 10.1021/ja104027w

Pluschke G, Tamborrini M. Virosomal technology in malaria vaccine development. Future Virology. 2010;5(3):247-250. DOI: 10.2217/fvl.10.24

Tamborrini M, Holzer M, Seeberger P.H, Schürch N, Pluschke G. Anthrax spore detection by a Luminex assay based on monoclonal antibodies recognizing anthrose-containing oligosaccharides. Clin Vaccine Immunol. 2010;17(9):1446-1451. DOI: 10.1128/CVI.00205-10

Tamborrini M, Liu X, Mugasa J.P, Kwon Y.U, Kamena F, Seeberger P.H, Pluschke G. Synthetic glycosylphosphatidylinositol microarray reveals differential antibody levels and fine specificities in children with mild and severe malaria. Bioorg Med Chem Lett. 2010;18:3747-3752. DOI: 10.1016/j.bmc.2010.04.059

Tamborrini M, Mueller M.S, Stoffel S.A, Westerfeld N, Vogel D, Boato F, Zurbriggen R, Robinson J.A, Pluschke G. Design and pre-clinical profiling of a Plasmodium falciparum MSP-3 derived component for a multi-valent virosomal malaria vaccine. Malar J. 2009;8:314. DOI: 10.1186/1475-2875-8-314

Tamborrini M, Oberli M.A, Werz D.B, Schürch N, Frey J, Seeberger P.H, Pluschke G. Immuno-detection of anthrose containing tetrasaccharide in the exosporium of Bacillus anthracis and Bacillus cereus strains. J Appl Microbiol. 2009;106(5):1618-1628

Tamborrini Marco. Use of synthetic carbohydrates as vaccine components and biomedical research tools. Basel: Univ. Basel, 2009. Doctoral Thesis, University of Basel, Faculty of Science DOI: 10.5451/unibas-004882238

Treeck M, Tamborrini M, Daubenberger C.A, Gilberger T.W, Voss T.S. Caught in action: mechanistic insights into antibody-mediated inhibition of Plasmodium merozoite invasion. Trends Parasitol. 2009;25(11):494-497. DOI: 10.1016/j.pt.2009.07.008

Kamena F, Tamborrini M, Liu X, Kwon Y.U, Thompson F, Pluschke G, Seeberger P.H. Synthetic GPI array to study antitoxic malaria response. Nat Chem Biol. 2008;4(4):238-240

Tamborrini M, Werz D.B, Frey J, Pluschke G, Seeberger P.H. Anti-carbohydrate antibodies for the detection of anthrax spores. Angew Chem Int Ed Engl. 2006;45(39):6581-6582